Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.22.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
 [1]
Current Assets:    
Cash and cash equivalents $ 57,376 $ 50,612
Restricted cash 17,361 11,513
Accounts receivable, net (net of allowance for doubtful accounts of $444 and $378, respectively) 92,744 86,888
Inventories 67,438 54,373
Derivative instruments 27,488 15,839
Notes receivable, current 3,125
Other current assets 11,081 7,176
Total current assets 273,488 229,526
Property and equipment, net 222,946 222,550
Other Assets:    
Right of use operating lease assets, net 14,004 13,413
Notes receivable, noncurrent 11,641
Intangible assets, net 9,381 2,678
Goodwill 5,908
Other assets 5,592 5,145
Total other assets 34,885 32,877
Total Assets 531,319 484,953
Current Liabilities:    
Accounts payable – trade 21,478 23,251
Accrued liabilities 21,404 21,307
Current portion – operating leases 4,132 3,909
Derivative instruments 32,770 13,582
Other current liabilities 15,340 7,553
Total current liabilities 95,124 69,602
Long-term debt, net of current portion 52,518 50,361
Operating leases, net of current portion 9,801 9,382
Other liabilities 10,288 10,394
Total Liabilities 167,731 139,739
Commitments and Contingencies (Note 7)
Alto Ingredients, Inc. Stockholders’ Equity:    
Preferred stock, $0.001 par value; 10,000 shares authorized; Series A: 1,684 shares authorized; no shares issued and outstanding as of June 30, 2022 and December 31, 2021; Series B: 1,581 shares authorized; 927 shares issued and outstanding as of June 30, 2022 and December 31, 2021; liquidation preference of $18,075 as of June 30, 2022 1 1
Common stock, $0.001 par value; 300,000 shares authorized; 74,188 and 72,778 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively 74 73
Non-voting common stock, $0.001 par value; 3,553 shares authorized; 1 share issued and outstanding as of June 30, 2022 and December 31, 2021, respectively
Additional paid-in capital 1,036,692 1,037,205
Accumulated other comprehensive loss (284) (284)
Accumulated deficit (672,895) (691,781)
Total Stockholders’ Equity 363,588 345,214
Total Liabilities and Stockholders’ Equity $ 531,319 $ 484,953
[1] Amounts derived from the audited consolidated financial statements for the year ended December 31, 2021.